Endocrine Abstracts

The prognosis of thyroid anaplastic carcinoma is poor. Yet can prognosis criteria change the therapeutic options?Method: From a series of 26 cases from a single group recorded between 1990 and 2006, we analyzed the outcome after treatment based on surgery, radio and chemotherapy and looked for prognosis criteria.Results: All but one patients died with a mean survival of 273 days (median survival of 130 days). Over 50% of patients h...

Thyroid anaplastic carcinoma (TAC) is rare among thyroid cancers. Few surveys on these diseases are available.Aim: To analyze the clinical and pathological characteristics of TAC in Auvergne, France, from a series of 26 patients among a cohort of over 1500 thyroid carcinomas (i.e. 1.7% of total thyroid cancers).Results: Mean age was 72.1 years (range 42–91 years), with a sex ratio of 19 women to 7 men. A previous history of th...